Analytical Data
-
Gene name
GK2
- Application
-
Alternative Names
ATP:glycerol 3-phosphotransferase 2Glycerol kinase, testis specific 2
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q14410
-
Expression Region
2-553aa
-
Molecular Weight
76.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GK2 (Glycogen Kinase 2) recombinant protein research has gained significant interest due to its potential roles in cellular metabolism and energy homeostasis. Glycogen kinases are crucial enzymes in glycogen metabolism, playing pivotal roles in glycogen synthesis and breakdown, processes that are essential for maintaining glucose levels and overall energy balance in living organisms. Abnormalities in glycogen metabolism can lead to metabolic disorders, including diabetes, obesity, and other related diseases. The investigation of GK2 at the molecular level has implications for understanding these pathways and developing therapeutic strategies. By utilizing recombinant DNA technology, researchers can produce GK2 in a controlled environment, allowing for detailed studies on its biochemical properties and interactions with other cellular components. Characterizing GK2 can reveal insights into its enzymatic mechanisms, regulatory networks, and impacts on cellular signaling pathways. Furthermore, exploring the structure-function relationship of GK2 may open avenues for drug design, targeting its activity to ameliorate metabolic diseases. The growing body of literature underscores the significance of GK2 in metabolic regulation, highlighting the necessity for continued research to fully elucidate its function and therapeutic potential.
